Cancer drug reverses Alzheimer's symptoms in mice
February 15, 2012
A drug that has been approved for the treatment of a type of skin cancer since 1999 appears to reverse Alzheimer's symptoms -- in mice.
Case Western Reserve University School of Medicine neuroscientist Gary Landreth and colleagues reported Thursday that bexarotene quickly cleared away beta-amyloid plaque, believed to cause the cognitive deficits of Alzheimer's disease, from the brains of genetically engineered mice.
Mice who received bexarotene treatment regained memory and cognitive function, including improvements in their sense of smell, the authors said. Bexarotene worked by helping to increase levels of a protein called Apolipoprotein E (ApoE), which helps remove beta-amyloids. Its effects took hold quickly, with half of plaques removed within 72 hours, the authors reported.
Paige Cramer, a Ph.D. candidate at Case Western Reserve, said in a statement that the research had produced "an unprecedented finding," noting that the previous best treatment for Alzheimer's in mice took several months to reduce plaque.
Scientists who weren't involved with the study (subscription required), which was published online in the journal Science, said that it suggested a tantalizing new avenue of inquiry for Alzheimer's drug research, but that even under the best of circumstances, it would take six years or longer before bexarotene might be used to treat people with the degenerative brain disease.
"Ultimately, you have to test this in humans," said Dr. Lon S. Schneider, an Alzheimer's researcher at USC's Keck School of Medicine in Los Angeles. Schneider said that efficacy trials would involve enrolling 1,000 patients for 18 months of treatment -- a process that would take more than three years. Further tests would take an additional couple of years.
And then the treatment would have to work, he added.
"It's very uncommon, so far, that treatments for mice translate for humans," he said. "People should not get immediately excited, or try to buy this drug from Canada."
Dr. George Bartzokis of the Brain Research Center at UCLA agreed that the track record for curing Alzheimer's in people with "mouse cures" was poor.
He said, though, that this kind of discovery is "exciting because it has the potential to give another clue in the puzzle of Alzheimer's disease."
Bartzokis said that he would like to have learned the effects of bexarotene on myelin (the fatty insulation that protects neurons) in the mice. "The medication these investigators used acted by increasing several enzymes...involved in building up and repairing myelin," he wrote in an e-mail. If the treatment turns out to help repair myelin in humans, it could have applications to several important diseases in addition to Alzheimer's disease.
By Eryn Brown, Los Angeles Times
Little Girl Lip Syncs 'Girls Like You' With Daddy And It's The Cutest Thing Ever
Teacher Finds Messages On Her Student's Pencils
Couple's Maternity Shoot In A Pumpkin Patch Has A Terrifying Ending
US Embassy Accidentally Invites People To Cat Pajama Party
Three Sisters Are Going As The Hocus Pocus Witches For Halloween
Police Officer's Heartfelt Plea Describes The Side Of The Job You Don't Read About In The News
Athlete With Cerebral Palsy Learns He's Been Signed By Nike
Someone Added Hilarious Captions To An Argument Between A French Bulldog And Mom
Watch This High School Dance Team's Magical Harry Potter Routine
Werewolf? Man Films Enormous Wolf During Late Night Drive
A Baby Tumbles Down A Hill On Live TV During A Rugby Match